Clinical Drug Experience Knowledgebase

Alzheimer Disease (Phase 3)

Anemia, Sickle Cell (Phase 2)

Arrhythmias, Cardiac (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Brain Concussion (Phase 1)

Breast Diseases (Phase 2)

Breast Neoplasms (Phase 2)

Bronchopulmonary Dysplasia (Phase 3)

Cardiovascular Diseases (Phase 3)

Child Development (Phase 3)

Cholangitis, Sclerosing (Phase 1)

Cognitive Dysfunction (Early Phase 1)

Colitis (Phase 1)

Colorectal Neoplasms (Phase 2)

Coronary Artery Disease (Phase 4)

Cystic Fibrosis (Phase 2)

Depression (Phase 3)

Diabetes, Gestational (Phase 1)

Fatty Acids (Phase 3)

Fatty Liver (Phase 3)

Genetic Diseases, X-Linked (Phase 2)

Gingivitis (Phase 2)

Healthy Volunteers (Phase 1)

HIV Infections (Phase 3)

Hypertension, Pregnancy-Induced (Phase 1)

Hypertriglyceridemia (Phase 2)

Infant, Premature, Diseases (Phase 2)

Inflammation (Phase 3)

Insulin Resistance (Phase 1)

Liver Cirrhosis (Phase 3)

Lung Neoplasms (Phase 2/Phase 3)

Macula Lutea (Phase 4)

Macular Degeneration (Phase 1)

Metabolic Syndrome (Phase 3)

Muscular Dystrophy, Duchenne (Phase 2)

Neonatology (Phase 3)

Non-alcoholic Fatty Liver Disease (Phase 3)

Obesity (Phase 3)

Oxidative Stress (Phase 2/Phase 3)

Parkinson Disease (Phase 1)

Periodontitis (Phase 2)

Pre-Eclampsia (Phase 1)

Pregnancy (Phase 3)

Premature Birth (Phase 3)

Psychotic Disorders (Phase 2)

Retinitis Pigmentosa (Phase 2)

Schizophrenia (Phase 2/Phase 3)